Our Key Priorities

We have launched a wide variety of Mucolytic API, Insecticides And Herbicides Chemicals, Active Pharmaceutical Ingredients, Anti Malarial API, etc. establishing a solid reputation for producing top-notch goods and gaining the confidence of devoted customers. Furthermore, our business specializes in offering "Make-to-order" generic pharmaceutical formulations, enabling bulk delivery to hospitals, corporate health centers, municipalities, and foreign export markets.

Additionally, we have successfully exported our goods to South East Asia, the Middle East, and North Africa (MENA Region), as well as other European nations like Indonesia, Sri Lanka, Japan, Ireland, England, Thailand, Vietnam, Singapore, Brazil, and Chile. This growth demonstrates our dedication to catering to a wider range of international customers.

Our Vision

Our goal is for our pharmaceutical firms to choose us as their go-to source for APIs.
By continuously delivering cutting-edge, client-focused, top-notch goods including APIs, Intermediates, and Finished Dosage Forms, we want to achieve long-term growth.

Our Mission

To function in a environmentally friendly & safe atmosphere.
To act with "integrity" when conducting business.
To guarantee that workers are content, inspired, and properly trained.

Core Values

Innovation- an organization's competitive edge is fueled by innovation. Innovation is highly valued at Cerata Pharma in a number of areas, including people, procedures, goods, and technology. We encourage innovation by fostering a culture of information exchange and cross-functional cooperation, which guarantees that new concepts and insights advance us in a distinctive and creative manner.
Focus- our API manufacturing company's main goal is to provide pharmaceutical goods that are safe, high-quality, and compliance. Throughout the manufacturing process, we place a high priority on strict quality control procedures, regulatory compliance, and strong safety regulations. While environmental responsibility and sustainable practices continue to be essential components of our operations, our steadfast dedication to research and development guarantees the innovation and optimization of our API production. Our attempts to offer dependable and reasonably priced API solutions to our international partners are motivated by patient welfare and customer happiness.
Integrity- integrity in the production of pharmaceutical APIs is non-negotiable and includes steadfast devotion to ethical behavior, regulatory compliance, and quality standards. It entails upholding truthful marketing techniques, transparent paperwork, and correct data records.
Safety- our first concern when creating APIs is safety. We uphold high standards of quality, closely adhere to environmental rules, and provide thorough training and safety measures to safeguard the well-being of our employees. With an emphasis on worker safety and product integrity, our dedication to safety encompasses danger assessments, emergency response plans, and continuous improvement.

Manufacturing Facilities

FDA-approved, WHO GMP, cGMP, and ISO 9001: 2015 certified is our manufacturing facility. Non-infringing APIs can be developed at our R&D center.

Currently, Cerata Pharmaceuticals LLP runs API production facilities in India's Himachal Pradesh and Gujarat. In 2025, a second production facility is planned to be established close to Ahmedabad, India.

Our two R&D centers provide innovations to our three manufacturing facilities. Numerous organizations, including the FDA, GMP, and WHO-GMP, have accredited these state-of-the-art manufacturing facilities.

Several top Big Pharma firms have conducted thorough audits of Cerata Pharmaceuticals LLP's manufacturing facilities in the areas of sustainability, quality, and environmental, health, and safety (EHS). Remarkably, Cerata has been selected as a partner for API needs by five of the top thirty Big Pharma firms in Asia, Africa, and America.

Under cGMP, Cerata Pharma's pilot facilities can handle a number of low-dose and extremely strong pharmaceuticals.

Cerata Pharmaceuticals LLP manufactures both non-potent and extremely potent active pharmaceutical ingredients (APIs) on a commercial basis.

We can supply API volumes in the range of grams to hundreds of tons, all of which are manufactured in accordance with strict cGMP (current good manufacturing practices) guidelines.

Our state-of-the-art production facilities at Cerata Pharmaceuticals LLP are evidence of our dedication to quality. These cutting-edge facilities meet the highest industry requirements for quality and are furnished with the newest technology.

Kilo Labs- Cerata Pharmaceuticals follows current good manufacturing practices (cGMP) at its Kilo Lab facility.
Pilot Plant- The pilot plants of Cerata Pharmaceuticals are essential to our dedication to producing pharmaceuticals in a safe and effective manner.
Commercial Scale- Our capacity allows us to successfully and efficiently handle a variety of production needs, with batch sizes as large as 6 metric tons.

Quality System

One of the top producers of intermediates and active pharmaceutical ingredients (API) is Cerata Pharmaceuticals LLP. We are steadfastly dedicated to our goal of meeting and continuously enhancing the caliber of our goods and services in order to continuously surpass the demands and expectations of our clients. Our commitment to excellence is demonstrated in the following ways:

Stringent Quality Standards
Continuous Improvement
Customer-Centric Approach
Research and Development
Quality Control
Compliance
Professional Team

Quality is a way of life at Cerata Pharmaceuticals LLP, not just an objective. We'll keep putting in endless effort to provide our esteemed clients with outstanding goods and services that not only fulfill but also beyond their expectations." Our state-of-the-art research and synthesis facilities, along with our Process Development and Support Centers, demonstrate Cerata Pharmaceuticals LLP's commitment to research, innovation, and environmentally responsible procedures. We are proud of our dedication to quality in the following areas:

Innovative Research and Synthesis Facility
Environmentally Responsible Process Development
Comprehensive Process Development and Scale-up
Process Support Centers

Quality Control

At Cerata Pharmaceuticals LLP, we are adamant that excellence is a sincere performance that demonstrates our commitment, not just a promise. Our operations revolve around quality control, and we go above and beyond to make sure that our products both meet and surpass the strictest industry requirements.

Advanced Quality Control Facilities
Comprehensive Quality Control
In-House Analytical Instruments

Quality Assurance

Our Quality Management System is closely monitored by Cerata's Regulatory Affairs and Quality Assurance departments. Through frequent system evaluations and ongoing improvement initiatives, we demonstrate our steadfast dedication to maintaining the highest standards in cGMP manufacturing. Notably, both of our manufacturing facilities have passed over 30 stringent cGMP audits that were carried out by various regulatory bodies. Furthermore, we have accepted more than 2000 quality audits from our esteemed clients, welcoming their input to continuously improve our business processes. Cerata's commitment to quality control is ingrained in our culture and guarantees that our products constantly fulfill exacting safety and effectiveness requirements.

Global Presence

Due to a number of circumstances, Cerata has become a leader in the API industry. We've proactively built a sizable amount of manufacturing capacity beforehand, created specialized production blocks with sizable batch capacities, and used backward integration to get necessary beginning materials.

We are steadfast in our resolve to be a trustworthy API supplier. By providing constant quality and affordable prices, we hope to enhance our clients' experiences. As the leading API manufacturer in the global pharmaceutical industry, our commitment to this role is demonstrated by continuous process improvements, engineering efficiencies, and the incorporation of Green Chemistry principles, all of which are intended to deliver consistent, high-quality APIs to clients worldwide.

From India, we export our medicines and APIs to markets in Asia, Africa, the Middle East, Europe, and America.

Global Regulatory Authorities, prominent Big Pharma and Multi-National Companies, Statutory Authorities, and Global Environmental, Health, and Safety teams have conducted thorough audits of Cerata Pharmaceuticals' API manufacturing sites. Our dedication to fulfilling and surpassing industry standards is demonstrated by these audits.

We take pride in offering dependable, cGMP-quality, and value-driven solutions for a variety of goods to the worldwide pharmaceutical sector. Our objective is centered on our commitment to quality and perfection, which guarantees that we constantly provide solutions that satisfy the highest industry standards.

Cerata Pharma is a reputable pharmaceutical API manufacturer from India and one of the biggest producers of active pharmaceutical ingredients (APIs) in the world.
Our GMP-certified facility produces our API drug products, and we also adhere to WHO-GMP and EU-GMP regulations.
We are one of the most reputable and prominent providers of API drugs to numerous ministries and organizations, such as the Global Fund, UNODC, UNOPS, South Africa, Mauritius, Brazil, Chile, Sri Lanka, Indonesia, Vietnam, Nepal, and Myanmar, among many others in Russia, the CIS, South Africa, Mauritius, and many more.

Our Strong API Expertise

API Synthesis

By carrying out versatile chemical reactions, process development and optimization, QBD implementation, solid-state characterization, polymorph screening, and chiral chemistry, we are involved in the full lifecycle of Active Pharmaceutical Ingredients (API), including the development and production of APIs and API intermediates.

R & D Capabilities

In Gujarat, India, we have a facility for research and development. We have developed a diverse array of intermediates and APIs thanks to our strong scientific capabilities in processes connected to API synthesis and our knowledge of chemistry. Our robust portfolio in important therapeutic areas, such as local anesthetic API, antibiotics/antibacterials API, antidiabetics API, antihypertensives API, antimalarial API, anticancer (oncology) API, antifungal API, and pain management API, has been made possible by this knowledge.

Regulatory

With a primary focus on foreign markets, Cerata Pharmaceuticals has extensive experience with worldwide regulations. Our API products are precisely engineered to meet stringent quality requirements at all times, thanks to our superior quality and strict commitment to GMP compliance. For regulatory matters, we have a dedicated team. By analyzing the most recent regulatory trends and quality requirements through proactive risk assessment and active surveillance, our team of regulatory specialists helps secure approval for each complex API. They also understand the complex challenges that regulatory agencies face. Cerata Pharmaceuticals produces and distributes premium, reasonably priced APIs to leading generic formulators worldwide, speeding up patients' access to affordable medications. We are the go-to API partner for pharmaceutical businesses around the world. Deep technological capabilities centered on the creation and production of sophisticated APIs are the foundation of our company's success. Our proficiency in intellectual property and regulatory issues supports this knowledge, enabling us to continuously exceed quality and regulatory requirements.

Quick Links

Our Products